InfuSystems Holdings (InfuSystems Holdings) Debt-to-Asset : 0.34 (As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

What is InfuSystems Holdings Debt-to-Asset?

InfuSystems Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.0 Mil. InfuSystems Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $34.9 Mil. InfuSystems Holdings's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was $102.9 Mil. InfuSystems Holdings's debt to asset for the quarter that ended in Dec. 2023 was 0.34.

InfuSystems Holdings Debt-to-Asset Historical Data

The historical data trend for InfuSystems Holdings's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InfuSystems Holdings Debt-to-Asset Chart

InfuSystems Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.54

0.44

0.38

0.37

0.34

InfuSystems Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Asset	Get a 7-Day Free Trial															0.37	0.39	0.39	0.36	0.34

Competitive Comparison of InfuSystems Holdings's Debt-to-Asset

For the Medical Instruments & Supplies subindustry, InfuSystems Holdings's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InfuSystems Holdings's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where InfuSystems Holdings's Debt-to-Asset falls into.

InfuSystems Holdings Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

InfuSystems Holdings's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	34.9)	/	102.915
	=	0.34

InfuSystems Holdings's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	34.9)	/	102.915
	=	0.34

InfuSystems Holdings (AMEX:INFU) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

InfuSystems Holdings Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of InfuSystems Holdings's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

InfuSystems Holdings (InfuSystems Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InfuSystems Holdings Inc (AMEX:INFU) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

1TZ:Germany

Address

3851 West Hamlin Road, Rochester Hills, MI, USA, 48309

Website

http://www.infusystem.com

InfuSystems Holdings Inc is a United States based healthcare service provider. It offers Infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care from the locations in the United States and Canada. The company provides products and services to hospitals, oncology practices and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The segments of the company are Integrated Therapy Services (ITS) and Durable Medical Equipment (DME) services, of which key revenue is derived from the ITS segment.

Executives

Jerod Funke	officer: EVP-Chief HR Officer	3851 WEST HAMLIN RD, ROCHESTER HILLS MI 48309
R. Rimmy Malhotra	director	C/O COMMAND CENTER, INC., 3609 S WADSWORTH BLVD., SUITE 250, LAKEWOOD CO 80235
Gregg Owen Lehman	director	309 HADDON COURT, FRANKLIN X1 37067
Richard Dilorio	officer: Executive Vice President	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Barry G Steele	officer: Executive VP and CFO	500 TOWN CENTER DR., SUITE 200, DEARBORN MI 48126
Carrie Lachance	officer: Executive VP and COO	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Christopher R. Sansone	director	C/O SANSONE ADVISORS, LLC, 151 BODMAN PLACE, SUITE 100, RED BANK NJ 07701
Addam Chupa	officer: Executive VP and CIO	3851 WEST HAMLIN ROAD, ROCHESTER HILLS MI 48309
Kevin Whitman	officer: VP and Corporate Controller	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Thomas Mark Ruiz	officer: VP of Sales and Marketing	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Boyd Ralph F Jr	director
Paul Andrew Gendron	director	740 BANDIT TRAIL, KELLER TX 76248
Jeannine Sheehan	officer: Chief Administrative Officer	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Blueline Capital Partners Ii, L.p.	director	3480 BUSKIRK AVENUE, SUITE 214, PLEASANT HILL CA 94523
Meridian Tsv Ii, Lp	10 percent owner	405 WEED STREET, NEW CANAAN CT 06840